单位:[1]Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-senUniversity, No.58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China院本部南沙医院东院内科消化内科内科消化内科内科消化内科中山大学附属第一医院[2]Department of Gastroenterology, The First Affiliated Hospital of ZhengzhouUniversity, Zhengzhou, China[3]Department of Gastrointestinal Surgery,Shandong Provincial Hospital Affiliated to Shandong University, No.324 JingwuRoad, Huaiyin District, Jinan 250021, China[4]Department of GastrointestinalOncology, Key Laboratory of Carcinogenesis & Translational Research underMinistry of Education, Peking University Cancer Hospital & Beijing Cancer Hospital,No.52 Fucheng Road, Haidian District, Beijing 100142, China[5]Department ofGastric Surgery, Sun Yat-sen University Cancer Center[6]State Key Laboratory ofOncology in South China[7]Collaborative Innovation Center for Cancer Medicine,Guangzhou, China[6]Department of Gastroenterology, Peking Union MedicalCollege Hospital, Beijing, China[7]Department of Integrative Oncology,China-Japan Friendship Hospital, Beijing, China[8]Department of MedicalOncology, Cancer Center, State Key Laboratory of Biotherapy, West ChinaHospital, West China Medical School, Sichuan University, Chengdu, China四川大学华西医院[9]Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center,Shanghai, China[10]Department of Gastroenterology, Nanfang Hospital, SouthernMedical University, Guangzhou, China[11]Department of Gastroenterology, UnionHospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China[12]Department of Pathology, Union Hospital, Tongji MedicalCollege, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属协和医院
Background: The clinicopathological characteristics of small intestinal neuroendocrine neoplasms (SI-NENs) and the prognostic validity of WHO grading classification for SI-NENs are still unknown in Asian patients. Methods: 277 patients and 8315 patients with SI-NENs were retrieved respectively from eleven Chinese hospitals and Surveillance, Epidemiology, and End Results (SEER) cancer registry. Overall survival was used as the major study outcome. Survival analysis using Kaplan-Meier analysis with log-rank test and cox regression analysis were applied. Results: Clinicopathological characteristics of SI-NENs were quite different among different races. Duodenum was the predominant tumor site in Chinese patients and Asian/Pacific Islander patients but not in white patients from SEER database. Patients with duodenal NENs tended to have more localized disease than patients with jejunal/ileal NENs which were confirmed by patients from SEER database. Grade 3 or poorly differentiated/undifferentiated tumor were more common and tumor size was significantly larger in ampullary NENs compared with that in non-ampullary duodenal NENs. As for the prognostic validity of WHO grading classification, survival between patients with grade 1 and grade 2 disease was not significantly different. Ki-67 index of 5% might be a better threshold between grade 1 and grade 2 than Ki-67 index of 2% in SI-NENs. Conclusions: Our study revealed that the clinicopathological characteristics of SI-NENs among different races were quite different. This might because duodenal NENs was much more common in Chinese patients and Asian/Pacific Islander patients. Duodenal NENs and jejunal/ileal NENs, ampullary and non-ampullary duodenal NENs shared different characteristics. Ki-67 index of 5% might be a better threshold between grade 1 and grade 2 in SI-NENs.
第一作者单位:[1]Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-senUniversity, No.58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China
通讯作者:
推荐引用方式(GB/T 7714):
Luohai Chen,Lin Zhou,Meng Zhang,et al.Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs[J].BMC CANCER.2017,17:doi:10.1186/s12885-017-3490-3.
APA:
Luohai Chen,Lin Zhou,Meng Zhang,Liang Shang,Panpan Zhang...&Jie Chen.(2017).Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs.BMC CANCER,17,
MLA:
Luohai Chen,et al."Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs".BMC CANCER 17.(2017)